 |
인쇄하기
취소
|
Korea neglects R&D for new drugs
Korea is not investing enough in research and development (R&D) projects for new drugs, a report showed recently. This partly explains why Korea is lagging behind others in the pharmaceutical industry, the report said.
According to the Korea Drug Research Association (KDRA), merely 10 percent of 802 pharmaceutical firms are engaged in the development of new drugs.
Currently, there are 26...
According to the Korea Drug Research Association (KDRA), merely 10 percent of 802 pharmaceutical firms are engaged in the development of new drugs.
Currently, there are 26...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.